SBC logo Authors: Amine Heddad, Andrea Krings, Markus Brameier and Bob MacCallum, Stockholm Bioinformatics Center, Stockholm University, Sweden.

NucPred

Fetching P98092 from www.uniprot.org...

The NucPred score for your sequence is 0.44 (see score help below)

   1  MRGGRDPVPVPVLGDYAMVCAKNGIILQWRYNVKECELSCTGGQQYTVCA    50
51 DSCLRKCSDTALAASGQCKPVCVEGCACSPSQLLDDNGVCVPVAKCPCIH 100
101 KGLQFNAGYKEIRPGRRERELCTCVGARWDCKPATPEEIQNYPPAEDLRS 150
151 NSTAQNMEFTTCETSEPLTCKNMHLPPSTQTAECRPGCQCKKGQVLDTAS 200
201 KRCVPATQCPCHHAGRSYPDGHLMQEECNKCECKNGNWSCTQRKCAGVCG 250
251 AWGDSHVNTFDGTQYDFEGVCTYLLAKGAMDGTDGFDVEIQNVPCGTTGA 300
301 TCSKSVTLKVGGAGNEEIVSLTKNAPIPDISKLKRIKMRKAGAYVFLDVP 350
351 SLGMSLQWDRGLRVYVKIDTMWQGRVKGLCGNYNGDMRDDFQTPSGGGMS 400
401 ESSALIFADSWKLKPTCPKPQPVIDHCKQRPERKEWAQSVCGALKRYPFS 450
451 LCAGEVGAGAYVARCERDACDAGADCECACAALAAYAHACAHRGVTFNWR 500
501 TNDLCPMQCDEVCSNYDSCVSACPVETCDNILYYAETTARCEQDTCVEGC 550
551 KPKKSCPEGSVYKNDSTTECVPRAKCKPVCMTLDGGREVLEGEIIEEDAC 600
601 HTCRCSKKHKVCTGQPCSTEAPRIQATSSSAEPATERPHEPLKCVTGWTP 650
651 WINRGPAEIGPDGQSVESEPLPKPNELQIGKPMCKPEMMKKIECRTVNDH 700
701 KTPKETGLNVECSLENGLVCEEPEKTCPDFEIKVYCECEEPQDTSPPVTV 750
751 TSEASSEPVSTTLATTTSRCPPGEVYQACAYKCDRLCDHFKKTLIAKGRC 800
801 ISEMCVDGCVDESVASNGCEGSSRWRDERTCVPVKDCTCYNDGQIVKPGG 850
851 VTESGCIKCQCLDNSLYCDSKDCVSLNIPHQGSTHLPYIVRPVSTTITST 900
901 TTTTTTSTTTTTTTPEPTETTTETTVPLIIKSTVSPPPECSPDNYIDLVM 950
951 GDEPLPDTAFSASSEFSEIFAPHNARLNRGPTNSGAGSWNPKVNNDKQYI 1000
1001 QVELPRREPIYGVVLQGSPIFDQYVTSYEIMYGDDGNTFSTVDGPDGKPK 1050
1051 IFRGPIDNTHPVKQMISPPIEAKVVRIRPLTWHDEISLRLEIIGCAEPLT 1100
1101 TETSEPSPTSESPLQCTEPLGLIGELPLENIQVSSNSEEKDYLSINGNRG 1150
1151 WKPLYNTPGWVMFDFTGPRNITGILTKGGNDGWVTSYKVLYTSDFETFNP 1200
1201 VIDKDGKEKIFPANFDGIVSVTNEFHPPIRARYLKVLPQKWNKNIELRIE 1250
1251 PIGCFEPYPEILRSLPEEEEGREEPQVVRKEYGMSQEREMPNCHICPGVE 1300
1301 AKECTCSYPEYFDGENCVPRAECPCVESFMTYPVGSTFRGANCDECVCKL 1350
1351 GGTTECKPFKECQCDDESLVPKLSPTTCDCTCEPCTNGTKICKTSKLCLA 1400
1401 LESWCDGVQDCPDDERDCTTSTARTTTTEPTVVTTVAPTQAATAPPTTTT 1450
1451 PKPVVECPKVECPPGYIISYTTGSSSSYSRAFSSDLPPPRPRYSYQRYYR 1500
1501 GRSTGGYSGYAKTGYSKGGFSKGGFSKGGYGYPSIPRSNQAFTLDKPALT 1550
1551 NKQPTSKEECAQFKCISKLPAFKPGVVPPPVACSVVTCPAGYTLKLDKVP 1600
1601 TGYNKCPQYECVPPLERPVFCNMTGRTFNTFDGMEYKYDVCFHMLARDNK 1650
1651 FDAWLIIVRKNCRLDGCTNELIVMQDDQLIQVKPNMMVTYNNYEYTIEQT 1700
1701 KKICFQKNSFDVDRLGNGISITSRKYNFTVLFNKEGDVKIGVLKKHMGGV 1750
1751 DGLCGAYDGSLANERRLPDGRVATSIDEFGRSWAKPGVPADACAPRVASA 1800
1801 HKQRRAWDLCNVIAEEPFSQCGKVLNLDKWRHICLEKICECTDLVVNGTK 1850
1851 RTEEQCRCLVLQQMAAECLAADAGVDLASWRLMMDCPADCPPPLVHYDCY 1900
1901 RKRCEETCAPYPNAARACPAQEGQCSPGCYCPDGKLRKGDQCVLPADCLD 1950
1951 CTCTGVGTPAKYTTFEGDDLPFLGNCTYLASRDRNQTGEHKYQVYATNGP 2000
2001 CDDNANIVCTKIVHLIYEKNVIHISKDPTTKKLRTVIGKTAVFKYPVKEN 2050
2051 WGTISLLNGQDVSVTLPDIHVELTVSQLNLEFAVRVPTFLYGNRTEGLCG 2100
2101 VCAGYQDFLVTSNGTVTDDFDLYGKSWQASPEKLTELEVPSDEQCDAPPP 2150
2151 PAPCTPPPPDNNTCYHLYNADRFGACHALVEPQPYVESCEADECGGHGPC 2200
2201 DALQRYAAACAELGLCLPDWRRELCPYPCEEPFVYRACVDCERTCDNYEQ 2250
2251 LQTSPEKCTNKPVEGCFCPEGKVRVNNTCIEPGKCFPCGVDGHYAGDEWQ 2300
2301 EDASTLCACARSPHGTALVGCRATSCAPPVCAHGEDLRTAPPPPGQCCPE 2350
2351 YDCVAKPEAQCKETKKIVCDYGQVLKQKTNPSGCKEYFCECKPSSECEVI 2400
2401 PPESEVEIVEAGIHREIDNSGCCPRVSLVCRPETCPKPPHCPQFQTLASV 2450
2451 NITGKCCPEYKCELPKDKCIVTLEWEAAAKGGEKPREKPQTVLKDLEAVW 2500
2501 LDGPCRSCECALSGAGPAATCAVSACPAVVSSELFVLEPRPVPFACCPEP 2550
2551 VQVACRHQDNVYKVGEKWKSPTDVCETYECAADGDGKLQRLAAVQRCDRH 2600
2601 CQPGWKYVPAEADSGQCCGKCEPVACVVDGEEKPIGEKWTSSDFCTNFTC 2650
2651 VNLNGTLQVQSSNETCPEISDAERKQFVLKEQKVPGKCCPKIEREACTSG 2700
2701 RSDIPGRRELDVDRELVRELPMRAGRGRRPALRGLRAALRDRLPTRLEVL 2750
2751 PAPAECCGRCKPSPASWKGGRGPSGRARERPVGESWTSADFCTNYTCADL 2800
2801 HGTLQVQSSNETCPEVSEAVKKQFVLKEEKIPGKCCPKVEPVACRDGDKI 2850
2851 YQEVQVWTTPDPCTNRTCRREDGQLSVGRTVEHCERQCRRGWTYSPPAAD 2900
2901 HCCGRCVQSACLVDDQLKEPGSTWSSADNCTTFSCDRSGEEVFVTSATEH 2950
2951 CPDVSACDPADIVNTTCCQICNEKPQALSKCVLRASELRHCRSDPHPMGA 3000
3001 HGLCVNKFPITGFTEVHGSCDSGTIYNNQTGTHESACECCQAAKYSGVSV 3050
3051 RLTCEDGTVRPHRVATPARCHCAACGPGLTKHPKPGHASYTGTKNPVQPE 3100
3101 RDREYVIPDISSASGEARRNHDSNYITTLIISF 3133

Positively and negatively influencing subsequences are coloured according to the following scale:

(non-nuclear) negative ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| positive (nuclear)

with NucPred



If you find NucPred useful, please cite this paper:
NucPred - Predicting Nuclear Localization of Proteins. Brameier M, Krings A, Maccallum RM. Bioinformatics, 2007. PubMed id: 17332022
The authors also look forward to your comments and suggestions.

What does the NucPred score mean?

You have to decide on a NucPred score threshold. Sequences which score greater than or equal to this threshold are predicted to spend some time in the nucleus. Higher thresholds yield fewer predicted nuclear proteins, but these predictions are more accurate (you can have higher confidence in them). The table below gives more details of the performance of NucPred estimated using the sequences it was trained on (by cross-validation). Another benchmark is available in the Bioinformatics 2007 paper.

NucPred score threshold Specificity Sensitivity
see above fraction of proteins predicted to be nuclear that actually are nuclear fraction of true nuclear proteins that are predicted (coverage)
0.10 0.45 0.88
0.20 0.52 0.83
0.30 0.57 0.77
0.40 0.63 0.69
0.50 0.70 0.62
0.60 0.71 0.53
0.70 0.81 0.44
0.80 0.84 0.32
0.90 0.88 0.21
1.00 1.00 0.02

Sequences which score >= 0.8 with NucPred and which are predicted by PredictNLS to contain an NLS have been shown to be 93% correct with a coverage of 16%. (PredictNLS by itself is 87% correct with 26% coverage on the same data.)

Go back to the NucPred Home Page.